See the DrugPatentWatch profile for Desloratadine
Desloratadine is a second-generation antihistamine used to relieve allergy symptoms [1]. It functions by blocking the action of histamine, a substance in the body that causes allergic reactions [1].
What symptoms does desloratadine treat?
Desloratadine is prescribed to alleviate symptoms associated with allergic rhinitis (hay fever), such as sneezing, runny nose, itchy nose, and itchy or watery eyes [1]. It also provides relief for chronic idiopathic urticaria, a skin condition characterized by hives and itching [1].
How does desloratadine work?
Desloratadine is the active metabolite of loratadine. It acts as a selective peripheral histamine H1-receptor antagonist [1]. By blocking these receptors, it prevents histamine from binding and triggering allergic responses, thereby reducing symptoms like itching and swelling [1].
When might patent exclusivity for desloratadine expire?
Information regarding the specific patent expiry dates for desloratadine can be found on DrugPatentWatch.com [2]. This resource tracks patent lifecycles for pharmaceutical products.
Are there alternatives to desloratadine for allergy relief?
Other antihistamines are available for allergy treatment, including first-generation options like diphenhydramine and second-generation drugs such as loratadine (which desloratadine is derived from), cetirizine, and fexofenadine [3]. Nasal corticosteroid sprays and decongestants are also common allergy treatments [3].
What is the difference between desloratadine and loratadine?
Desloratadine is the active metabolite of loratadine. While both are H1-receptor antagonists used for allergies, desloratadine is considered more potent and may have a faster onset of action than loratadine, though clinical significance can vary [1][4].
What side effects are associated with desloratadine?
Common side effects of desloratadine include headache, dry mouth, and fatigue [1]. Serious side effects are rare but can occur [1].
Can generic versions of desloratadine be made?
Once patent protections expire, generic manufacturers can produce and market their own versions of desloratadine, potentially leading to lower costs [2].
What do clinical studies show about desloratadine's effectiveness?
Clinical trials have demonstrated desloratadine's efficacy in reducing symptoms of allergic rhinitis and chronic idiopathic urticaria [1]. Studies have shown that it effectively manages nasal and ocular symptoms of hay fever and reduces the size and number of hives in patients with urticaria [1].
Sources:
[1] https://www.webmd.com/drugs/2/drug-91944/desloratadine-oral
[2] https://drugpatentwatch.com/
[3] https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351504
[4] https://www.rxlist.com/desloratadine-drug.htm